Veterinary Medicines

Suibiofer Se (586 mg + 0,998 mg + 0,00403 mg + 0,03 mg + 0,01 mg + 0,0025 mg + 0,08 mg + 0,4 mg)/ml, surowica świńska do 1 ml Roztwór do wstrzykiwań

Authorised
  • RIBOFLAVIN SODIUM PHOSPHATE
  • PORCINE SERUM
  • Copper sulphate, anhydrous
  • Sodium selenite pentahydrate
  • Iron dextran
  • Cyanocobalamin
  • Nicotinamide
  • Pyridoxine hydrochloride
  • Thiamine hydrochloride
Download as PDF

Product identification

Medicine name:
Suibiofer Se (586 mg + 0,998 mg + 0,00403 mg + 0,03 mg + 0,01 mg + 0,0025 mg + 0,08 mg + 0,4 mg)/ml, surowica świńska do 1 ml Roztwór do wstrzykiwań
Active substance:
  • RIBOFLAVIN SODIUM PHOSPHATE
  • PORCINE SERUM
  • Copper sulphate, anhydrous
  • Sodium selenite pentahydrate
  • Iron dextran
  • Cyanocobalamin
  • Nicotinamide
  • Pyridoxine hydrochloride
  • Thiamine hydrochloride
Target species:
  • Pig
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • RIBOFLAVIN SODIUM PHOSPHATE
    0.01
    milligram(s)/millilitre
    /
    1.00
    milligram(s)/millilitre
  • PORCINE SERUM
    1.00
    millilitre(s)
    /
    1.00
    millilitre(s)
  • Copper sulphate, anhydrous
    0.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium selenite pentahydrate
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Iron dextran
    586.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    0.08
    milligram(s)
    /
    1.00
    millilitre(s)
  • Nicotinamide
    0.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyridoxine hydrochloride
    0.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Thiamine hydrochloride
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        5
        week
  • Subcutaneous use
    • Pig
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09A
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Drwalewskie Zakłady Przemysłu Bioweterynaryjnego S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1121
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 6/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."